Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 5.5B | 5.7B | 5.5B | 5.3B |
Cost of revenue | 1.1B | 1.1B | 1.1B | 1.0B |
Gross profit | 4.5B | 4.6B | 4.4B | 4.3B |
Operating expense | ||||
Research & development | 1.1B | 1.5B | 909M | 953M |
Selling general and admin | 2.8B | 2.3B | 2.5B | 2.0B |
Other operating expenses | — | — | — | — |
Operating income | 177M | 811M | 1.0B | 1.3B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 680M | 732M | 1B | 1.3B |
Tax provision | 90M | -45M | 230M | 301M |
Net income | 590M | 777M | 770M | 1.0B |
Basic EPS | — | 0.8 | 0.8 | 1.0 |
Diluted EPS | — | 0.8 | 0.8 | 1.0 |
Basic average shares | — | 996.2M | 987.2M | 992.1M |
Diluted average shares | — | 996.2M | 987.2M | 992.1M |
EBITDA | 739M | 811M | 1.0B | 1.3B |
Net income from continuing op. | 177M | 811M | 1.0B | 1.3B |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |